These child deaths are a largely preventable tragedy. A vaccine against pneumococcal disease exists and is being used in the UK. The impact of this vaccine has been seen in England and Wales where there has been a 59% reduction of cases of invasive pneumococcal disease among children under the age of two since it was introduced in September 2006 (4).
But developing countries, who account for more than 90% of pneumococcal deaths, do not have access to these vaccines. The UK Parliamentarians urge donor and developing countries to continue their commitment to fighting this killer disease through vaccination, strengthening healthcare systems, sustained political will, funding for research and international coordination of efforts.
"We have a responsibility to help reduce the global health problem of pneumococcal disease, which is under-recognised and until recently, has had few dedicated efforts made to tackle it," said Chair of the Group Dr. Des Turner, MP. "The APPG developed this report in response to the urgent need to improve child survival and tackle the devastating impact of pneumococcal disease in the developing world. As we've highlighted, governments and international organisations have a crucial role to play in preventing pneumococcal disease in the developing world, and need to maintain and grow commitments to mobilise the resources needed to fight the disease."
Additionally, the report covers the disease burden, financing and also the future of the fight against pneumococcal disease.
"We commend APPG's recommendation to elevate pneumococcal disease alongside other global killers including AIDS, malaria and TB," said Dr Orin Levine, Executive Director, GAVI's PneumoADIP. "Vaccination is a proven, safe and effective solution to the global burden of this deadly disease. It is vital that the donor community maintain and increase their commitment, ensuring these vaccines are made available to those who need them most."
To ensure the introduction of lifesaving vaccines to developing countries, the first pilot Advance Market Commitment (AMC), a novel financing mechanism, is investing in accelerating the introduction of this vaccine to where it is needed most, the developing world. The AMC for pneumococcal disease is expected to make an important contribution to saving the lives of over 7 million children by 2030 (5).
GAVI Executive Secretary Julian Lob-Levyt said, "New financing mechanisms such as an AMC have the potential to save millions of lives. To reach Millennium Development Goal 4, which calls for a two-thirds reduction in childhood mortality by 2015, we must urgently use solutions like the AMC to provide dramatic and rapid impact. Ensuring faster access for children to a vaccine against pneumococcal is a fundamental step towards this goal."
Prof Tumani Corrah, Unit Director & Chairman, Executive Management Board, MRC in The Gambia, said, "Countries in Africa and across the developing world see the impact of pneumococcal disease on our families on a daily basis. The All Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World is doing an invaluable job in raising the profile of this forgotten but devastating disease. As their report states, it is essential that governments across the world remain committed to fighting this deadly bacteria."
Evidence for the report was gathered from across the globe from individuals, governments, multi-laterals, NGOs, funding organisations and the pharmaceutical industry.
1. For further information about pneumococcal disease, the All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World, or to download a full version of the report please visit: www.appg-preventpneumo.org
2. Interviews are available with spokespeople quoted above and representatives of the APPG.
For further information or to organise an interview, please contact:Georgina Pinnington
Georgina Pinnington | EurekAlert!
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
21.08.2017 | Medical Engineering
21.08.2017 | Materials Sciences
21.08.2017 | Life Sciences